期刊文献+

MicroRNAs通过调节自噬影响乳腺癌的耐药性 被引量:4

MicroRNAs involved in drug resistance of breast cancer by regulating autophagy
原文传递
导出
摘要 自噬是一种保守的分解代谢过程,其特征在于通过溶酶体依赖性途径降解和再循环胞质成分或细胞器。它与乳腺癌的耐药性有着复杂而密切的关系。小分子核糖核酸(micro RNA,mi RNA)是小的非编码分子,可通过基因表达的转录后调控来影响众多细胞过程,包括自噬。许多蛋白质和途径能调节自噬,而其中一些反过来又被mi RNA调节。另外,这些mi RNA可能会影响乳腺癌的耐药性。耐药性是乳腺癌患者远处复发、转移和死亡的主要原因。在这篇综述中,我们总结了乳腺癌自噬与药物耐药性之间的因果关系,同时还讨论了自噬相关蛋白和途径及其相关的mi RNA在乳腺癌耐药性中的作用。 Autophagy is a conserved catabolic process characterized by degradation and recycling of cytosolic components or organelles through a lysosome-dependent pathway.It has a complex and close relationship to drug resistance in breast cancer.MicroRNAs(miRNAs)are small noncoding molecules that can influence numerous cellular processes including autophagy,through the posttranscriptional regulation of gene expression.Autophagy is regulated by many proteins and pathways,some of which in turn have been found to be regulated by miRNAs.These mi RNAs may affect the drug resistance of breast cancer.Drug resistance is the main cause of distant recurrence,metastasis and death in breast cancer patients.In this review,we summarize the causative relationship between autophagy and drug resistance of breast cancer.The roles of autophagy-related proteins and pathways and their associated miRNAs in drug resistance of breast cancer are also discussed.
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2020年第9期690-702,共13页 浙江大学学报(英文版)B辑(生物医学与生物技术)
基金 Project supported by the Department of Science and Technology of Sichuan Province,China(No.2019YFH0146) the Health Commission of Sichuan Province,China(Research Project on Healthcare in Sichuan Province,No.2019-107)。
关键词 自噬 小分子核糖核酸(microRNA) 乳腺癌 耐药 Autophagy MicroRNA Breast cancer Drug resistance
  • 相关文献

参考文献1

二级参考文献73

  • 1American Cancer Society. Available from: http://www.cancer. org/doctor/home/index.asp.
  • 2Anzick SL, Kononen J, Walker RL, et al. AIB 1, a steroid re- ceptor coactivator amplified in breast and ovarian cancer. Sci- ence 1997; 277:965-968.
  • 3Cai D, Shames DS, Raso MG, et al. Steroid receptor coacti- vator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res 2010; 7fl:6477-6485.
  • 4Dihge L, Bendahl PO, Grabau D, et al. Epidermal growth fac- tor receptor (EGFR) and the estrogen receptor modulator am- plified in breast cancer (AIB 1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. Breast Cancer Res Treat 2008; 109:255-262.
  • 5Osborne CK, Bardou V, Hopp TA, et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in ta- moxifen resistance in breast cancer. J Natl Cancer Inst 2003; 95:353-361.
  • 6Chen HW, Lin RJ, Xie W, Wilpitz D, Evans RM. Regulation of hormone-induced histone hyperacetylation and gene acti- vation via acetylation of an acetylase. Cell 1999; 98:675-686.
  • 7Feng Q, Yi P,-Wong JM, O'Malley BW. Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a mo- lecular switch for complex disassembly. Mol Cell Biol 2006; 26:7846-7857.
  • 8Wu RC, Qin J, Yi P, et al. Selective phosphorylations of the SRC-3/AIB 1 coactivator integrate genomic responses to mul- tiple cellular signaling pathways. Mol Cell 2004; 15:937-949.
  • 9Conroy H, Mawhinney L, Donnelly SC. Inflammation and cancer: macrophage migration inhibitory factor (MIF)-the potential missing link. QJM2010; 103:831-836.
  • 10Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate im- mune response, Proc NatlAcadSci USA 2002; 99:345-350.

共引文献13

同被引文献17

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部